Group One Trading
TNGX icon

Group One Trading’s Tango Therapeutics TNGX Stock Holding History

Group One Trading’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$107K Buy
5,100
+4,100
+410% +$57.1K ﹤0.01% 4661
2025
Q4 		$8.86K Sell
1,000
-3,000
-75% -$25.8K ﹤0.01% 6875
2025
Q3 		$33.6K Buy
+4,000
New +$27.1K ﹤0.01% 6276
2024
Q2 		– Sell
-400
Closed -$3.18K – 7490
2024
Q1 		$3.18K Buy
+400
New +$4.29K ﹤0.01% 6354

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Group One Trading's TNGX Position: Q3 2025 in Review

Group One Trading sold out of Tango Therapeutics (TNGX) in Q3 2025, closing a stake of 1,400 shares — an estimated $9.47K sold.

Group One Trading first reported a position in TNGX in Q2 2025 and held it in 1 quarter. The position peaked at $7.17K in Q2 2025. 141 funds tracked by Wall St. Rank hold TNGX as of Q3 2025.

  • Group One Trading reported no remaining Tango Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 1,400 Tango Therapeutics shares in Q3 2025, an estimated $9.47K.
  • Group One Trading first reported a position in Tango Therapeutics in Q2 2025 and held it in 1 quarter.
  • Group One Trading's Tango Therapeutics position peaked at $7.17K in Q2 2025.
  • 141 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.